Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
High blood pressure
MedTech
Medtronic claims long-sought FDA approval in renal denervation
Medtronic claimed the FDA's second green light in renal denervation this month, as it competes with Recor for a potential multibillion-dollar market.
Conor Hale
Nov 20, 2023 10:21am
J&J hands back $230M blood pressure drug with approval in sight
Sep 6, 2023 6:20am
Medtronic, ReCor back renal denervation approach to hypertension
Sep 20, 2022 2:51pm
J&J's $230M blood pressure bet hits phase 3 endpoint
May 23, 2022 8:57am
Digital health coach Noom nets $540M to tackle diabetes and more
May 25, 2021 11:25am
Onduo’s virtual clinic expands into multiple chronic conditions
Feb 3, 2021 11:37am
